TuHURA Biosciences HURA
NASDAQ HURA
$1.52 +0.01 (+0.66%)
At close: Nov 11, 2026 · 4:00 PM EST

TuHURA Biosciences (HURA) Revenue (2024 - 2025)

Updated

Analysis

TuHURA Biosciences (HURA) Revenue (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.40 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 17.40 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 15.07 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 8.30 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 16.58 Bn
10 TuHURA Biosciences 96.16 Mn 82.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -608,142.00
Sep 30, 2025 -10,472.00
Jun 30, 2025 65,062.00
Mar 31, 2025 44,757.00
Sep 30, 2024 -1.60 Mn
Jun 30, 2024 -1.32 Mn
API Access

TuHURA Biosciences Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=HURA&period=max&api_key=YOUR_API_KEY